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Mitochondrion is one of the master players in both apoptosis and necrosis. We studied the role of mitochondrial function in TRAIL-induced apoptosis. TRAIL killed SK-Hep1 cells with characteristic features of apoptosis such as DNA fragmentation, sub-G1 ploidy peak and cytochrome c translocation. In contrast, mitochondrial DNA-de®cient SK-Hep1 r 0 cells were resistant to TRAIL. Dissipation of mitochondrial potential or cytochrome c translocation did not occur in r 0 cells after TRAIL treatment. TRAIL induced translocation of Bax subsequent to the cleavage of Bid in parental cells. However, Bax translocation was absent in r 0 cells, accounting for the failure of cytochrome c release in r 0 cells. Forced expression of Bax induced caspase-3 activity in r 0 cells. Incubation of r 0 cells with ADP+Pi to increase intracellular ATP restored sensitivity to TRAIL. Despite dierent sensitivity to TRAIL, parental cells and r 0 cells did not show signi®cant dierence in susceptibility to agonistic antiFas antibody, TNF-a or staurosporine. Our results indicate that TRAIL-induced apoptosis is dependent on intact mitochondrial function and susceptibility of mitochondrial DNA-de®cient cells to apoptosis depends on the type of apoptotic stimuli. Tumor cells with mitochondrial mutations or dysfunction might have the ability to evade tumor surveillance imposed by TRAIL in vivo.
Introduction
Members of the TNF and TNF receptor family play critical roles in the regulation of apoptosis, in¯amma-tion, growth and development. As a new member of the TNF family, TNF-related apoptosis-inducing ligand (TRAIL) has been reported to kill a wide variety of transformed cells including those resistant to other TNF family members (Grith et al., 1998; Thomas and Hersey, 1998) . TRAIL does not kill most normal cells (Grith et al., 1998; Walczak et al., 1999) except certain hematopoietic cells (Jeremias et al., 1998; Wang et al., 1999) , suggesting the potential therapeutic role of TRAIL in the treatment of advanced cancer. Cellular receptors for TRAIL were also cloned. Besides authentic TRAIL receptors-DR4 (Pan et al., 1997) and DR5 (Chaudhary et al., 1997) , decoy TRAIL receptors were identi®ed and found to be expressed preferentially on normal cells potentially explaining the lack of TRAIL activity on them (Pan et al., 1998; Sheridan et al., 1997) . However, recent papers failed to ®nd a correlation between decoy receptor expression and resistance to TRAIL, obscuring the molecular mechanism of dierential sensitivity to TRAIL (Lincz et al., 2001; Wuchter et al., 2001) . Signal pathway downstream of TRAIL receptors is also not clearly understood, while signal transduction by other TNF receptor family members was extensively studied. Activation of caspases was reported in TRAIL-induced apoptosis (Grith et al., 1998; Yamada et al., 1999) . However, the role of Fas-associated death domain protein (FADD) or NF-kB activation in TRAIL-induced apoptosis has been equivocal (Schneider et al., 1997; Yeh et al., 1998) , and that of mitochondria has not been systematically studied.
Mitochondrion is the organelle where the majority of cellular ATP is generated through oxidative phosphorylation. Mitochondrion is also one of the master players in both apoptosis and necrosis, two classical modes of cell death. While morphological changes of mitochondria such as swelling and appearance of occulent densities have been regarded as the hallmarks of necrosis (Kerr et al., 1995) , mitochondria also play an important role in apoptosis by releasing cytochrome c and thereby activating caspase-9 (Li et al., 1997; Liu et al., 1996) . Mitochondrial permeability transition (PT) is observed in a large number of apoptotic events and has been described as a point-ofno-return of death programming (Kroemer et al., 1997) (Jacobson et al., 1993; Jiang et al., 1999; Liang and Ullyatt, 1998; Marchetti et al., 1996) . In contrast, some r 0 cells were more resistant to TNF-induced apoptosis than their parental cells, suggesting the necessity of oxidative phosphorylation in certain types of apoptosis (Higuchi et al., 1997) .
We conducted this investigation to study the role of mitochondrial function in TRAIL-induced apoptosis.
Results

Resistance of mitochondrial DNA-deficient cells to TRAIL
Colorimetric assays using crystal violet showed that 10*1000 ng/ml TRAIL killed parental (r + ) human hepatoma cells (SK-Hep1) after incubation for 24 h in a dose-dependent manner (Figure 1a ). Hoechst 33342 staining of nuclei showed markedly increased nuclear condensation and fragmentation (see Figure 5d ).
Apoptosis by 250 ng/ml TRAIL was inhibited by a pan-caspase inhibitor (z-VAD-fmk), a caspase-3 inhibitor (Ac-DEVD-fmk) or a caspase-8 inhibitor (Ac-IETD-fmk) of 50 mM concentration each (Figure 1b) , suggesting that TRAIL-induced r + cell death was a classical caspase-dependent apoptosis. DNA ploidy assays also showed that the death of SK-Hep1 cell by TRAIL was the classical apoptosis accompanied by sub-G1 DNA peak (Figure 1c,d) . In contrast, mtDNAde®cient r 0 (SK-Hep1) cells were resistant to TRAILinduced apoptosis. They remained viable after incubation with TRAIL for 24 h (Figure 1a) . After TRAIL treatment for 24 h, there was virtually no increase in the number of apoptotic cells with nuclear condensation/fragmentation identi®ed by Hoechst 33342 staining (see Figure 5h) . The dierence in their susceptibility to TRAIL was not due to the dierence in the expression of TRAIL receptors because parental SK-Hep1 cells and r 0 cells expressed agonistic DR5 TRAIL receptors of similar level (Figure 2 ). Both cells did not express other agonistic receptor-DR4 or decoy receptors (DcR1, DcR2). The addition of 100*1000 ng/ml actinomycin D rendered r 0 cells sensitive to TRAIL, indicating that the resistance of r 0 cells to TRAILinduced apoptosis could be overcome with actinomycin D (Figure 1a ). Morphological changes of mitochondria after TRAIL treatment TRAIL treatment of r + cells for 12 h induced morphological changes in mitochondria. Mitochondrial size became variable after TRAIL treatment. Mitochondrial swelling and loss of cristae were observed in some mitochondria. Outer membrane continuity was interrupted in some mitochondria, indicating the loss of membrane integrity (Figure 3b ). In untreated r 0 cells, the size of mitochondria was variable and some of them were huge in size (Figure 3c ). The number of cristae was also decreased in r 0 cells, and some cristae were cylindrical in shape. However, discontinuity of the mitochondrial membrane was not observed in r 0 cells.
Signi®cant morphological changes such as loss of membrane integrity were not observed after TRAIL treatment of r 0 cells (Figure 3d ), consistent with the absence of r 0 cell death by TRAIL.
Effect of mitochondrial DNA depletion on cytochrome c translocation Consistent with the morphological changes of mitochondria, TRAIL treatment of r + cells for 12 h triggered dissipation of mitochondrial potential measured by¯ow cytometric measurement of¯uorescence after loading of mitochondrial membrane-permeable cationic dye DiOC 6 (Figure 4a ). However, dissipation of mitochondrial potential was not observed in TRAIL-treated r 0 cells (Figure 4b) . We next studied possible translocation of cytochrome c after TRAIL treatment of r + cells for 12*24 h. Fluorescent staining using nuclear chromatin-binding Hoechst 33342 and FITC-visualized anti-cytochrome c antibody showed that cytochrome c was dispersed diusely in the whole cytoplasm of apoptotic cells undergoing nuclear condensation/fragmentation (Figure To elucidate the mechanism of the absence of cytochrome c translocation in r 0 cells, we studied the changes of caspase-8, Bid, and Bax that constitute upstream of cytochrome c translocation. Immunoblot analyses showed that 250 ng/ml TRAIL treatment for 6*12 h induced the cleavage of caspase-8 in both r Next, we studied the translocation of Bax that reportedly accompanies the cleavage of Bid in TNFainduced apoptosis (Perez and White, 2000) . Before TRAIL treatment, Bax was diusely stained in the cells (Figure 7a ). However, a large proportion of r + cells displayed a punctuate mitochondrial pattern of Bax immunostaining after TRAIL treatment for 12*24 h, which suggests the translocation of Bax facilitating recognition by anti-Bax antibody (Figure 7d ). Triplecolored staining with a mitochondria-selective dye MitoTracker Red, Hoechst 33342 and anti-Bax antibody con®rmed that the punctate perinuclear Bax was indeed localized to mitochondria of r + cells undergoing nuclear condensation/fragmentation ( Figure  7e ,f). Such cells showing Bax translocation constituted 55.3% of total r + cells after TRAIL treatment, in contrast to 4.3% before TRAIL treatment (Figure 7a) . However, the percentage of such cells did not signi®cantly increase after TRAIL treatment of r 0 cells (4.6?12.3%) (Figure 7g,j) , suggesting that the absence of Bax translocation is responsible for the absence of cytochrome c release and also the lack of TRAIL sensitivity in r 0 cells. To con®rm the absence of Bax translocation in SK-Hep1 r 0 cells, immunoblot analyses after cell fractionation were carried out. Bax expression in the cytosolic fraction was decreased while it was increased in the heavy membrane fraction by 250 ng/ml TRAIL treatment of SK-Hep1 parental cells for 12 h, indicating that TRAIL induces Bax translocation from cytosolic fraction to heavy membrane fraction. However, Bax expression remained stationary in both heavy membrane and cytosolic fractions before and after TRAIL treatment of SK-Hep1 r 0 cells, strongly indicating that Bax translocation did not occur in r 0 cells (Figure 8 ). To further prove the role of the absence of Bax translocation in SK-Hep1 r 0 cells, they were transiently transfected with Bax because the overexpression of Bax has been reported to lead to caspase activation and cell death in some cell types (Jia et al., 2001) . Forced overexpression of 3 mg human Bax cDNA induced caspase-3 activity as measured by caspase substrate assays while that of less amount of Bax (1 mg) did not, suggesting that Bax overexpression probably abrogated the inability of r 0 cells to translocate Bax and led to the activation of caspases (Figure 9 ).
Because previous papers reported the necessity of ATP hydrolysis in transporting proteins from cytoplasm into mitochondria (Alberts et al., 1994) and that SK-Hep1 r 0 cells have defects in ATP generation (Park et al., 2001) , we next studied if the correction of ATP de®ciency in r 0 cells could overcome the resistance of r 0 cells to TRAIL. Incubation in a medium containing 2 mM ADP and Pi which had been reported to increase intracellular ATP (Jia et al., 1996) induced TRAIL susceptibility in otherwise resistant r 0 cells, indicating that the de®ciency in ATP generation is responsible for the absence of Bax translocation and the upregulation of mitochondrial respiration is able to abrogate TRAIL resistance in SK-Hep1 r 0 cells (Figure 10 ). 
Figure 8
Bax translocation after TRAIL treatment assessed by cell fractionation studies. Bax expression in the cytosolic fraction was decreased while it was increased in the heavy membrane fraction after 250 ng/ml TRAIL treatment of r + cells for 6*12 h. However, changes in the Bax expression were not observed in the heavy membrane and cytosolic fractions after TRAIL treatment of r 0 cells
We next studied the downstream event of Bax and cytochrome c translocation in parental cells and r 0 cells. Caspase-9 cleavage occurred in r + cells but not in r 0 cells after treatment with 250 ng/ml TRAIL for 12*24 h, as expected from the cytochrome c release noted only in r + cells (Figure 11a ). Cleavage of caspase-3, one of the most important ®nal eectors in apoptosis, was also observed in r + cells but not in r 0 cells after treatment with 250 ng/ml TRAIL for 24 h (Figure 11b ).
Apoptosis of r 0 cells by other apoptotic stimuli
Because r 0 cells were resistant to TRAIL in contrast to parental r + cells, we studied whether r 0 and r + cells have dierent susceptibility to other apoptotic stimuli. Despite dierent sensitivity to TRAIL, parental r + cells and r 0 cells did not show signi®cant dierence in their susceptibility to agonistic anti-Fas antibody (CH-11), TNFa or staurosporine. Both r + and r 0 cells did not undergo apoptosis after treatment with 100 ng/ml anti-Fas antibody or 10 ng/ml TNFa. However, they were killed by TNFa or anti-Fas antibody in the presence of 1 mg/ml actinomycin D (Figure 12a ). Both r + and r 0 cells underwent apoptosis after treatment with 1 mM staurosporine for 24 h, which was accompanied by dissipation of mitochondrial potential (Figure 12b,c) and cytochrome c translocation from mitochondria to cytosol (data not shown). (Perez and White, 2000) . Translocation of Bax to mitochondria has been reported in several apoptosis models including those induced by TNF or staurosporine Perez and White, 2000; Wolter et al., 1997 ). In the current study, we demonstrated that TRAIL also induced translocation of Bax which was absent in SKHep1 r 0 cells. The role of the absence of Bax translocation in the resistance of r 0 cells to apoptosis was shown by the successful induction of caspase-3 activity by Bax overexpression. The mechanism of the absence of Bax translocation in TRAIL-treated r 0 cells is not clear. Our experimental data together with previous reports suggest that insucient amounts of ATP produced in r 0 cells is most likely responsible for the absence of Bax translocation and resistance to TRAIL. Firstly, the transport of proteins into mitochondria has been reported to require ATP hydrolysis (Alberts et al., 1994) . Secondly, ATP content in SKHep1 r 0 cells is signi®cantly lower compared to their parental cells in both the resting and stimulated states (Park et al., 2001) . Thirdly, the replenishment of ATP in r 0 cells by addition of ADP/Pi induced susceptibility to TRAIL. Other potential abnormalities in the internal milieu of mitochondria such as pH might also contribute to the absence of Bax translocation in r 0 cells (Khaled et al., 1999) . Reactive oxygen species did not appear to be involved in TRAIL-induced SK-Hep1 cell death or Bax translocation because antioxidants such as butylated hydroxyanisole (BHA), N-acetylcysteine (NAC) or Trolox were ineective in modulating cell death by TRAIL (Lee et al., unpublished results).
Mitochondrial potential was dissipated in r + cells after TRAIL treatment, which is consistent with a previous report (Thomas et al., 2000) . In r 0 cells, mitochondrial potential measured by¯ow cytometric measurement was detected. However, its dissipation did not occur after TRAIL treatment of r 0 cells. This ®nding is consistent with the absence of cytochrome c translocation in r 0 cells, while dissociation between cytochrome c release and mitochondrial potential change has been reported (Bossy-Wentzel et al., 1998) . Previous papers employing mammalian cells or yeast reported that mitochondrial potential is preserved in mitochondrial DNA-depleted cells, owing to compensatory adenine nucleotide translocator function allowing countertransport of adenine nucleotides across the mitochondrial membrane (Buchet and Gedinot, 1998; Drgon et al., 1991; Skowronek et al., 1992) . No signi®cant basal and glucose-stimulated mitochondrial proton gradient previously observed in SK-Hep1 r 0 cells might be due to the dierence in the method of measurement between¯ow cytometry and quenching method (Park et al., 2001) .
Loss of outer mitochondrial membrane integrity observed in electron microscopic analysis of r + cells after TRAIL treatment is consistent with the loss of mitochondrial potential and cytochrome c translocation in them. Mitochondrial swelling and rarefaction of cristae were also observed. Morphological changes of mitochondria have been described in necrosis rather than apoptosis, however, recent papers reported such changes in classical apoptosis (Vander Heiden et al., 1997) .
The importance of cytochrome c and dissipation of mitochondrial potential in apoptosis has been demonstrated in numerous previous reports. However, susceptibility of mitochondrial DNA-depleted cells to apoptosis seems to vary according to the kind of apoptotic stimuli and also cell types. Most r 0 cells are reportedly susceptible to apoptosis by serum deprivation, TNF/cycloheximide or anti-cancer drugs, like their parental cells (Jacobson et al., 1993; Liang and Ullyatt, 1998; Marchetti et al., 1996) . However, some r 0 cells were most resistant to TNF-induced cell death than their parental cells (Higuchi et al., 1997; Schulze-Ostho et al., 1993) . SK-Hep1 r 0 cells were resistant to TRAIL unlike their parental cells in the current study, however, their susceptibility to other apoptotic stimuli such as agonistic anti-Fas antibody, TNFa or staurosporine was not signi®cantly dierent compared to their parental cells. Because SK-Hep1 r 0 cells were resistant to TNFa or anti-Fas antibody alone as well as TRAIL alone, we cannot conclude that SK-Hep1 r 0 cells are selectively resistant to TRAIL. However, sensitivity or resistance to TNFa or anti-Fas antibody was not dierent between r + and r 0 cells, while resistance to TRAIL was observed only in r 0 cells. Thus, the resistance of mitochondrial DNA-depleted cells seems to be dependent on the type and strength of apoptotic stimuli. In fact, actinomycin D that decreases apoptotic threshold in a variety of cells (Rubin et al., 1988) rendered r 0 cells sensitive to TRAIL as it overcame the resistance of r + and r 0 cells to TNFa or anti-Fas antibody. These results are consistent with a previous report showing actinomycin D-mediated overcoming of r 0 cell resistance to TNFa (Schulze-Ostho et al., 1993). The mechanism of actinomycin D in the abrogation of r 0 cell resistance to TRAIL is not clear. Previous papers suggested that the inhibition of NF-kB-inducible antiapoptotic gene induction by actinomycin D might be important for sensitization of target cells to apoptotic stimuli (Jones et al., 2000; Van Antwerp et al., 1996) . However, we could not detect NF-kB DNA-binding nuclear complex after TRAIL treatment of either r + or r 0 cells while TNFa treatment clearly induced NF-kB activation in both r + and r 0 cells (Lee et al., unpublished results), suggesting that the sensitization of r 0 cells to TRAIL-induced apoptosis by actinomycin D is independent of NF-kB activation. However, we tested only SK-Hep1 hepatoma r 0 cells and our results regarding the resistance of r 0 cells to apoptosis and its abrogation cannot be generalized, given the apparently dierent behavior of various r 0 cells (Higuchi et al., 1992; Jacobson et al., 1993; Liang and Ullyatt, 1998; Marchetti et al., 1996; Schulze-Ostho et al., 1993) .
The clinical or biological signi®cance of r 0 cell resistance to TRAIL is not clear at the moment because the physiological function of TRAIL itself is not clearly understood. A few papers described the potential physiological function of TRAIL related to dendritic cell-related killing and CD4 + T cell activity Kayagaki et al., 1999a; Wang et al., 1999) . Because TRAIL has been reported to be expressed on natural killer (NK) cells or monocytes upon appropriate stimuli Kayagaki et al., 1999b) and TRAIL is active on the majority of tumor cells, TRAIL might be involved in tumor surveillance in vivo. A direct involvement of TRAIL on NK cells in the surveillance of tumor metastasis has been shown in recent in vivo experiments Takeda et al., 2001) . Several papers reported prevalent mitochondrial mutations in a variety of tumors (Fliss et al., 2000; Polyak et al., 1998) . Then tumor cells with mutations in mitochondrial genes may have diminished mitochondrial function and consequently decreased susceptibility to TRAIL, which might serve as a selection advantage over normal cells with intact mitochondrial function.
Materials and methods
Derivation of r 0 cells
SK-Hep1, human hepatoma cells, were grown in DMEM-10% FBS (r + cells). Cells were cultured in the presence of 100 ng/ml ethidium bromide to inhibit mitochondrial DNA replication for more than 20 generations until use (r 0 cells) (Park et al., 2001) . r 0 cells were derived and maintained in the presence of 50 mg/ml uridine. PCR analysis using primers speci®c for human mtDNA showed the absence of mtDNA in the r 0 cell genome (Park et al., 2001) . The total cellular enzyme activity of cytochrome c oxidase whose three subunits are encoded by mtDNA was profoundly decreased in r 0 cells, while that of succinate dehydrogenase whose subunits are all encoded by nuclear DNA was not decreased in r 0 cells (Park et al., 2001) . ATP production was also severely impaired in r 0 cells, re¯ecting the absence of oxidative phosphorylation (Park et al., 2001) . All these ®ndings indicated that r 0 cells used in this study were authentic mtDNA-de®cient cells.
TRAIL treatment and assessment of cytotoxicity TRAIL was expressed and puri®ed as a soluble form from Escherichia coli, as previously described (Cha et al., 1999 (Cha et al., , 2000 . After TRAIL treatment, supernatant was removed and 100 ml 0.2% crystal violet solution (Junsei, Tokyo, Japan) in 2% ethanol was added to each well. After incubation at room temperature for 1 h, wells were washed with tap water to remove the staining solution. Once the wells were dried, 100 ml 0.5% SDS was added to each well. After stirring vigorously in an orbital shaker for 30 min, absorption at 570 nm was measured with a microplate reader. To inhibit caspases, z-VAD-fmk, Ac-DEVD-fmk or Ac-IETD-fmk (Enzyme Systems, Livermore, CA, USA) was added 30 min before TRAIL treatment. In some experiments, CH-11 antiFas antibody (Upstate Biotechnology, Lake Placid, NY, USA), TNFa (Calbiochem, San Diego, CA, USA) or staurosporine (Calbiochem) was used instead of TRAIL. In experiments studying the role of ATP in TRAIL susceptibility, r 0 cells were cultured in a medium containing 2 mM ADP (Sigma, St. Louis, MO, USA) and K 2 HPO 4 , pH 7.2 for 1 week before TRAIL treatment. Culture medium was replaced by fresh ADP-containing medium every 2 days.
TRAIL receptor expression
The expression of agonistic and decoy receptors for TRAIL was explored by¯ow cytometric analyses using biotinylated anti-DR4 (DJR1), -DR5 (DJR2-2), -DcR1 (DJR3) or -DcR2 (DJR4-2) antibody. These monoclonal antibodies have been raised against, and speci®cally reacted to DR4-Ig, DR5-Ig, DcR1-Ig and DcR2-Ig, respectively (Yagita et al., unpublished results). Cells were detached and suspended in PBS-2.5% horse serum ± 0.05% sodium azide (PSA) containing appropriately diluted primary antibody. After incubation at 48C for 30 min and washing in PSA, cells were incubated with FITC-streptavidin in PSA at 48C for 30 min before¯ow cytometry.
Morphological analysis of apoptotic cells
Morphological changes in the nuclear chromatin of cells undergoing apoptosis were detected by staining with 2.5 mg/ ml of DNA-binding bisbenzimide Hoechst 33342¯uoro-chrome (Calbiochem). Transmission electron microscopy was carried out essentially as previously described (Shimizu et al., 1996) . In brief, cells were ®xed in 4% glutaraldehyde/1% paraformaldehyde/0.2 M phosphate (pH 7.2) at 48C for 2 h. After two washes in 0.2 M phosphate, the cell pellets were post®xed with 2% OsO 4 in the same buer for 30 min. Pellets were dehydrated in ethanol and then in 100% propylene oxide, followed by embedding at 378C overnight and at 608C for another 3 days. Ultra®ne sections were cut and examined on an electron microscope (Hitachi H7100, 75 kV).
Measurement of mitochondrial potential
DiOC 6 (Molecular Probes, Eugene, OR, USA) was added to 5*10610 6 cells suspended in 0.5 ml PBS to a ®nal concentration of 20 nM. After incubation at 378C for 15 min, emission at 500 nm was measured by¯ow cytometry. For a control shift, 5 ml of 50 mM mCICCP (Sigma) was added together with DiOC 6 .
Immunofluorescence
Cells were cultured on chamber slides. After TRAIL treatment for 6*24 h, the cells were washed with DMEM-10% FBS and incubated in a medium containing 100 nM MitoTracker Red (Molecular Probes) for 30*45 min. The cells were washed twice in PBS and ®xed with 4% paraformaldehyde for 30 min at room temperature. The cells were further ®xed in ice-cold 100% methanol for 10 min. After three washes with PBS, nonspeci®c binding was blocked with 2% horse serum ± 0.5% Triton X-100 ± 0.02% NaN 3 in PBS for 20 min. The cells were then incubated with anti-cytochrome c (PharMingen, La Jolla, CA, USA) or antiBax antibody (Upstate Biotechnology) in PBS at room temperature for 90 min. After three washes with PBS, the cells were incubated with FITC-conjugated secondary antibody for 40 min, washed three times in PBS and then incubated with 3 mg/ml Hoechst 33342 (Molecular Probes) for 3 min. After three ®nal washes with PBS, the slides were mounted for observation on a¯uorescent microscope. More than 200 cells from more than ®ve ®elds were counted in each experiment.
Immunoblot analyses
Cells were lysed in triple-detergent lysis buer (50 mM TrisCl, pH 8.0, 150 mM NaCl, 0.02% sodium azide, 0.1% SDS, 1% NP-40, 0.5% sodium deoxycholoate, 1 mM PMSF) as described (Sambrook et al., 1989) . Protein concentration in cell lysate was determined using a protein assay kit (Bio-Rad, Hercules, CA, USA). An equal amount of protein for each sample was separated by 10 or 12% SDS ± PAGE and transferred to Hybond nitrocellulose membranes (Amersham, Buckinghamshire, UK). The membranes were blocked with 5% skim milk and incubated with 1 : 1000*1 : 2000 dilution of antibody to caspase-8 , caspase-9 (PharMingen), caspase-3 (kindly provided by Dr Suh P-G, Pohang University of Science and Technology, Pohang, Korea) or Bid (Santa Cruz Biotechnology, Santa Cruz, CA, USA). Blots were then probed with appropriate horse radish peroxidase-conjugated secondary antibody. Bound antibody was visualized using an enhanced chemiluminescence reagent (Pierce, Rockford, IL, USA).
Cell fractionation
Cell fractionation was conducted according to a published protocol (Gross et al., 1998) . Brie¯y, SK-Hep1 parental cells and r 0 cells were lysed in an isotonic buer containing 10 mM HEPES, 250 mM sucrose, 1 mM EDTA, 1 mM EGTA, 1 mM DTT, 2 mM PMSF and 100 mg/ml leupeptin. After douncing with a pestle, lysate was centrifuged at 600 g, 48C for 10 min. Nuclear pellet was suspended in a buer containing 10 mM HEPES, 5 mM MgCl 2 , 42 mM KCl and 1% Triton X-100. After centrifugation of the supernatant at 15 000 g, 48C for 10 min, the heavy membrane fraction was suspended in the same buer. Cytosolic fraction was separated from the light membrane fraction by ultracentrifugation at 100 000 g, 48C for 60 min. The purity of the nuclear, heavy membrane and cytosolic fraction was con®rmed by immunoblot analyses using anti-PARP, -Cox4 and -IkB antibody, respectively. The expression of Bax in the heavy membrane fraction and cytosolic fraction before and after TRAIL treatment was carried out by immunoblot analyses using anti-Bax antibody (Upstate Biotechnology).
Transfection of Bax
SK-Hep1 r 0 cells seeded in six-well plates were transfected with 1*3 mg of human Bax cDNA (kindly provided by Dr JC Reed, Burnham Institute, La Jolla, CA, USA) using lipofectAMINE reagent (Gibco ± BRL, Grand Island, NY, USA), according to the supplier's instruction. Twenty-four hours after the transfection, cells were lysed for caspase-3 substrate assays using a commercial kit (PharMingen). Fluorogenic substrate (Ac-DEVD-AMC) was then incubated with the cell lysate at 378C for 1 h. AMC liberated from Ac-DEVD-AMC or Ac-IETD-AMC was measured using ā uorometric plate reader with an excitation wavelength of 380 nm and an emission wavelength of 420*460 nm.
